Ohio Public Employees Retirement System (OPERS)’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$538K Hold
50,324
﹤0.01% 1479
2026
Q1
$556K Hold
50,324
﹤0.01% 1454
2025
Q4
$1.02M Buy
50,324
+8,871
+21% +$156K ﹤0.01% 1336
2025
Q3
$656K Buy
41,453
+15,350
+59% +$227K ﹤0.01% 1456
2025
Q2
$348K Buy
+26,103
New +$352K ﹤0.01% 1564

Other funds holding KROS

Ohio Public Employees Retirement System (OPERS)'s KROS Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) held its Keros Therapeutics (KROS) position steady in Q2 2026 at 50,324 shares worth $538K. The position accounts for ﹤0.01% of the portfolio, ranked #1479.

Ohio Public Employees Retirement System (OPERS) first reported a position in KROS in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.02M in Q4 2025. 132 funds tracked by Wall St. Rank hold KROS as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) held 50,324 shares of Keros Therapeutics worth $538K as of Q2 2026.
  • Ohio Public Employees Retirement System (OPERS) left its Keros Therapeutics share count unchanged in Q2 2026.
  • Keros Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #1479 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Keros Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Keros Therapeutics position peaked at $1.02M in Q4 2025.
  • 132 funds tracked by Wall St. Rank held Keros Therapeutics as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.